CClinicalTrials.gg
CompletedNCT03614208ESSE2016Updated Aug 3, 2018

Individualized Home-based Exercise Program for Patient With Systemic Sclerosis.

An interventional study of Home-care rehabilitation group (HCRG) in Systemic Sclerosis, sponsored by Universita di Verona. Completed at 1 site in Italy. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2018-08-03.

Sponsored by Universita di Verona · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Feb 2017, registered Jul 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Systemic sclerosis (SSc) is an uncommon chronic rheumatic disease with an unknown cause and unpredictable course. The inability, in addition to easy fatigability, starts a vicious circle that leads to a fast deterioration of physical conditions that cause a reduction of aerobic exercise capacity and, consequently, of health-related quality of life (HRQoL). Aerobic exercise has already been shown to be safe and effective in improving exercise capacity and HRQoL of patients with chronic cardiovascular and pulmonary diseases. However, few studies have evaluated the role of specific exercise programs on the muscular impairment in SSc. Nevertheless, the results obtained in preliminary reports are promising, and, for these reasons, the management of muscular impairment in SSc could include an appropriate rehabilitation program besides pharmaceutical and surgical treatments.

The primary aim of this study will be to evaluate the effect of an individualized exercise program performed at home on aerobic capacity evaluated by 6 minutes walking test.

Secondary aims will be to evaluate: 1- VO2max, measured by cardiopulmonary test; 2- the effect of the same program on the muscular strength of upper and lower limbs; 3- the efficacy of a self-administered stretching program for finger joint motion. Secondary aims will be also 1-to ascertain whether a comprehensive exercise program may affect, besides physical function, HRQoL; 2- and to evaluate the adherence during two periods of three months, one whit and one without supervision and reinforcement by a phone call.

All the patients with a diagnosis of SSc, according to the criteria of American College of Rheumatology (ACR), who attended the Rheumatologic outpatient clinic of our institution will be evaluated in order to participate in the rehabilitation program. The pneumological examination and two days of screening and testing will take place at the outpatient's clinic of Respiratory Medicine and Sport of our institution.

Read the detailed description

This will be a randomized, controlled, six months parallel group study. The flow chart of the study is reported in table 1. Participants initially will undergo 2 days of screening and testing. During the first visit patients will sign an informed consent, will undergo clinical assessment, pulmonary function testing, measurement of anthropometric data and body composition by bioimpedentiometry. They will perform a graded exercise test on a cycloergometer and will complete questionnaires to assess HRQoL (short form-36, SF-36) and functional abilities (health assessment questionnaire disability index, HAQ-DI). During the second visit, the participants will carry out the hand mobility in scleroderma test (HAMIS), six minutes walking test (6MWT), will undergo measurements of quadriceps and biceps strength, and handgrip test. After completion of testing and screening, patients who will meet the selection criteria will be randomly assigned to one of two groups 1) home-care rehabilitation group (HCRG); 2) control group (CG). The first group will begin a six months program of exercise training. The patients of the second group will be given generic recommendations to increase physical activity.

The patients in the first group, during a session in our outpatient clinic, will be instructed by a physiotherapist how to perform the physical exercise program at home. In particular, they will learn how to use the stationary bike and how to perform the exercises for upper limbs. Furthermore, the patient of the first group will be instructed how to fill in a card in which they will record the exercises performed daily. Throughout the first three months of the training period, the patients received a phone call from a physiotherapist once monthly, during which the adherence to exercise program will be reinforced. Particularly, it will be asked about the adherence to and the acceptance of exercise program, and the presence of side effects. Also, the control group will receive a phone call with the same schedule, but only in order to evaluate health status and to give a general recommendation about the positive effect of the aerobic exercise. From the third to the sixth month, both groups will not receive a monthly call, in order to evaluate the adherence to the program in the absence of supervision.

After 3 and 6 months, the subjects will undergo a complete 2 days of testing, using the same schedule described for a baseline.

The exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week.

A stationary cycle (Energetics ct220p, Neomark Sarl, Luxembourg) will be given to each patient for lower limb training. Each session will consist of three phases. In the first one, the patient will pedal for 5 minutes without inserting the brake. In the second phase, the patient will be instructed to set the brake at a load equal to 60% of the watts achieved at the peak of the maximal ergocycle exercise test. This phase consists in two periods of fifteen minutes divided by recovery interval of three minutes. It will be followed by five minutes of cool-down without load. The frequency of pedalling will be about 60 rotation/min during the second phase and less than 50 during the other phases.

For upper limbs training the patients will perform ten repetitions for three times that consists in lifting and lowering repeatedly a weight from the waist to the shoulders, alternating periods of exercise and three minutes of rest. The load will be calculated as the 60% of predicted 1-RM. Warm up and stretching of upper limbs, shoulders and neck will be performed before and after each exercise session respectively.

For the first two weeks, for both types of exercises of the program, the load will be reduced by 20%.

For finger stretching to the patients will be given written and illustrated instructions on self-administered exercises, and will be directed to perform it every day, both in the morning and in the evening.

During the rehabilitation period, the patients will report each day on a diary for each type of exercise whether the tasks were complete, partially or not executed which corresponds a score of 1, 0.5, 0 respectively.

The attendance rate at the training session will be calculated by the ratio between the amount of the score obtained from the diary and the scheduled sessions multiplied for 100.

02

Conditions studied

  • Systemic Sclerosis

Keywords

  • Systemic sclerosis
  • Home based rehabilitation
  • Quality of life
  • Hand mobility
  • Exercise capacity
03

In context

Scleroderma, Systemic

688 studies on the registry are indexed under Scleroderma, Systemic; 223 are open to participants now.

This study's enrollment of 33 is close to the median of 34 across 493 interventional studies indexed under Scleroderma, Systemic.

Browse Scleroderma, Systemic studies →

Lead sponsor

Universita di Verona is the lead sponsor of 122 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of SSc according to the criteria of ACR
  • no hospitalizations in the previous 3 months
  • no change in anti-rheumatic treatment in the previous 3 months
  • signed informed consent

Exclusion criteria

Exclusion Criteria:

  • heart failure staging in classes III or IV of New York Heart Association (NYHA)
  • pulmonary hypertension, defined by echocardiogram as a right ventricular systolic pressure ≥ 45mmHg
  • vital capacity (VC) ≤ 50% or diffusion lung capacity of carbon monoxide (DLCO) ≤ 30% of predicted values.
  • renal failure defined as a calculated glomerular filtration rate (GFR) \< 30ml/min, in agreement with the staging of International Federation of National Kidney Foundations
  • inability to perform the rehabilitation program due to skeletal-muscle impairments or other illnesses
  • pregnancy or planned pregnancy in the next 6 months
  • psychiatric disorders that prevent collaboration and adherence at the rehabilitation the program, including drug abuse
  • involvement in ongoing aerobic or anaerobic exercise programs

Drop out criteria:

  • the demonstration of ischemic heart disease after cardiopulmonary exercise testing performed at baseline
  • need to change the dosage or interruption of prostanoids used in the treatment of SSc during the 6 months of the treatment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    Home-care rehabilitation group (HCRG)

    The home-based exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week. For finger stretching the patients will be directed to perform it every day, both in the morning and in the evening. During the rehabilitation period, the patients will report each day on a diary for each type of exercise. They received a phone call monthly, only for the first 3 months, to encourage them about the adherence and investigate any problems with the exercise program.

    Behavioral: Home-care rehabilitation group (HCRG)

  • No intervention
    Control group

    Control group was encouraged to perform the generic aerobic physical activity at the baseline. Also, they received a monthly phone call, only for the first 3 months, to encourage them about the importance of doing aerobic exercise.

Interventions

  • BehavioralHome-care rehabilitation group (HCRG)

    The exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week.

    Also known as: Experimental group

06

What researchers measure

Primary outcomes

  1. Six minute walking test

    Evaluate aerobic capacity

    Time frame: Up to six months

Secondary outcomes

  1. Maximum oxygen consumption (VO2max)

    Evaluate the maximum volume of oxygen that a human can consume in the unit of time, measured by cardiopulmonary test

    Time frame: Up to six months

  2. Handgrip strength

    Handgrip strength will be measured in kilograms using a hydraulic hand-held dynamometer (Saehan Corp., Masan, Korea).Will be recorded, for each hand, the best result between three attempts.

    Time frame: Up to six months

  3. Muscular strength of upper limbs

    Biceps strength will be measured in kilograms by an isometric forearm flexion using a dynamometer (Kern CH50K50, Kern\&Sohn, Balingen, Germany) perpendicularly fixed on the floor. Will be recorded, for each arm, the best result between three attempts.

    Time frame: Up to six months

  4. One repetition maximum (1-RM) of biceps strength

    One repetition maximum (1-RM) of biceps strength, expressed in kilograms, will be determinated by using the submaximal estimation method (predicted 1-RM) with the formula of Brzycke.

    Time frame: Up to six months

  5. Muscular strength of lower limbs

    Quadriceps strength will be measured in kilograms by an isometric leg extension. The subject will be seated in an adjustable, straight-backed chair with the lower leg unsupported and the hip and knee flexed in a 90° angle, with an adjustable belt around the hips. Isometric leg extension strength will be measured by a dynamometer (Kern CH50K50, Kern \& Sohn, Balingen, Germany) applied with a strap around the ankle just proximal to malleoli. Will be recorded, for each lower limb, the best result between three attempts.

    Time frame: Up to six months

  6. Hand Mobility in Scleroderma test (HAMIS-test)

    Evaluate finger joint motion and hand function

    Time frame: Up to six months

  7. Short Form - 36 (SF-36)

    It is a self-reported questionnaire for evaluating the health status. It contains 36 items, measuring quality of life with two summary measures, a physical component score (PCS) and a mental component score (MCS).

    Time frame: Up to six months

  8. Health assessment questionnaire - disability index (HAQ-DI)

    This questionnaire indicates the extent of functional abilities. It consists in 20 items divided into eight categories. For each one of the items the score can range from 0 (lack of disability) to 3 (complete disability).

    Time frame: Up to six months

  9. Adherence to exercise program, only for treatment group

    Evaluate the adherence, using a diary, during two periods of three months, one whit and one without supervision and reinforcement by phone call

    Time frame: Up to six months

07

Study locations

1 site
  • Azienda Ospedaliera, SSO respiratory pathophysiology Unit, Verona
    Verona, Italy/Verona 37134, Italy
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03614208
Lead sponsor
Universita di Verona
Responsible party
Marcello Ferrari (Professor, Universita di Verona) — Principal investigator
First posted
Aug 3, 2018
Start date
Feb 1, 2017
Primary completion
Mar 1, 2018
Completion
Mar 1, 2018
Last update
Aug 3, 2018

Study contacts

Marcello Ferrari, Professor
principal investigator · Universita di Verona

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion